Bank of America’s Array Biopharma Inc ARRY Stock Holding History

Bank of America’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-400,000	Closed	-$5.7M	–	7619
2018 Q4	$5.7M	Hold	400,000	–	–	﹤0.01%	2859
2018 Q3	$6.08M	Hold	400,000	–	–	﹤0.01%	3002
2018 Q2	$6.71M	Buy	400,000 +100,000	+33%	+$1.59M	﹤0.01%	2849
2018 Q1	$4.9M	Sell	300,000 -20,100	-6%	-$322K	﹤0.01%	3102
2017 Q4	$4.1M	Buy	+320,100	New	+$3.64M	﹤0.01%	3308

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

Bank of America's ARRY Position: Q3 2019 in Review

Bank of America sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 772,474 shares — an estimated $35.8M sold.

Bank of America first reported a position in ARRY in Q2 2013 and held it in 25 quarters. The position peaked at $35.8M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Bank of America reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Bank of America sold 772,474 Array Biopharma Inc shares in Q3 2019, an estimated $35.8M.
Bank of America first reported a position in Array Biopharma Inc in Q2 2013 and held it in 25 quarters.
Bank of America's Array Biopharma Inc position peaked at $35.8M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Bank of America's 13F filing for Q3 2019, filed 14 Nov 2019.